Spatial Genomics And Transcriptomics Market Report 2026

Spatial Genomics And Transcriptomics Market Overview

• Spatial Genomics And Transcriptomics market size has reached to $1.7 billion in 2025 • Expected to grow to $3.02 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Its Role In Enabling Targeted, Gene-Based Therapies • Market Trend: Pioneering Spatial Transcriptomics Technology Enables High-Resolution Gene Expression Mapping • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Spatial Genomics And Transcriptomics Market?

Spatial genomics and transcriptomics refer to techniques that map the spatial organization of gene expression and genetic information within tissues, allowing researchers to study how cells in their native environment interact and contribute to various biological processes or diseases. These approaches provide a detailed, high-resolution view of gene activity within specific tissue locations, offering insights into cellular heterogeneity, disease mechanisms, and potential therapeutic targets. The main types of products in spatial genomics and transcriptomics are instruments, consumables, and software. An instrument is a device or tool used for scientific purposes, including the study of both natural phenomena and theoretical research. It includes various technologies such as spatial transcriptomics, sequencing-based methods, immunohistochemistry (IHC), microscopy-based RNA imaging techniques, and spatial genomics, useful for various applications including diagnostics, translational research, drug discovery and development, single-cell analysis, cell biology, and others. It is used in pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes.

What Is The Spatial Genomics And Transcriptomics Market Growth Forecast?

The spatial genomics and transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $3.02 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to personalized oncology demand, drug discovery applications, single-cell analysis growth, computational biology expansion, clinical translation focus. Major trends in the forecast period include growth of spatial mapping technologies, integration of ai analytics, rising oncology research adoption, expansion of academic collaborations, increased pharma investment.

Global Spatial Genomics And Transcriptomics Market Segmentation

1) By Product: Instruments, Consumables, Software 2) By Technology: Spatial Transcriptomics, Sequencing-Based Methods, Immunohistochemistry (IHC), Microscopy-Based RNA Imaging Techniques, Spatial Genomics 3) By Application: Diagnostics, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes Subsegments: 1) By Instruments: Sequencing Platforms, Imaging Systems, Fluorescence Microscopes, Slide Scanners, Flow Cytometers 2) By Consumables: Reagents And Kits, Slides And Coverslips, Probes And Tags, Sample Preparation Consumables 3) By Software: Data Analysis And Visualization Tools, Image Analysis Software, Workflow Management Software, Cloud-Based Analytics Platforms

What Is The Driver Of The Spatial Genomics And Transcriptomics Market?

Increasing adoption of personalized medicine is expected to propel the growth of the spatial genomics and transcriptomics market going forward. Personalized medicine is a healthcare approach that tailors treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors to enhance treatment effectiveness and minimize side effects. The demand for personalized medicine is increasing due to advancements in genetic research, which allow for more precise treatments tailored to an individual’s unique genetic makeup, leading to better patient outcomes. Spatial genomics and transcriptomics enable personalized medicine by revealing the precise location and activity of genes within tissues, allowing for targeted, individualized treatment strategies based on a patient’s unique molecular landscape. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the spatial genomics and transcriptomics industry.

Key Players In The Global Spatial Genomics And Transcriptomics Market

Major companies operating in the spatial genomics and transcriptomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., BioSpyder Technologies Inc.

Global Spatial Genomics And Transcriptomics Market Trends and Insights

Major companies operating in the spatial genomics and transcriptomics market are focusing on developing innovative solutions, such as spatial transcriptomics technologies, to enhance our understanding of gene expression in the context of tissue architecture. Spatial transcriptomics technologies refer to advanced techniques that map gene expression across tissue samples while preserving their spatial context, enabling researchers to study the location and distribution of RNA molecules within tissues. For instance, in February 2025, Illumina Inc., a US-based biotechnology company, introduced a pioneering spatial transcriptomics technology that significantly advances the ability to map and analyze gene expression within complex tissues at cellular resolution. Offering a capture area nine times larger and four times higher resolution than existing methods, it enables unbiased, whole-transcriptome profiling with high sensitivity. Compatible with Illumina’s NextSeq and NovaSeq sequencers and integrated into the Illumina Connected Multiomics platform, this technology facilitates comprehensive multiomic data analysis.

What Are Latest Mergers And Acquisitions In The Spatial Genomics And Transcriptomics Market?

In April 2024, Bruker Corporation, a US-based manufacturer of scientific instruments and analytical solutions, acquired NanoString Technologies for an undisclosed amount. Through this acquisition, Bruker Corporation aims to enhance its spatial biology portfolio with complementary gene expression and spatial transcriptomics solutions, positioning the company as a market leader and driving innovation, revenue growth, and long-term value in the post-genomic era. NanoString Technologies is a US-based biotechnology company that offers both spatial genomics and spatial transcriptomics solutions.

Regional Outlook

North America was the largest region in the spatial genomics and transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Spatial Genomics And Transcriptomics Market?

The spatial genomics and transcriptomics market includes revenues earned by entities by providing services such as spatial gene expression profiling, single-cell RNA sequencing, spatially resolved transcriptome analysis, cancer and disease research, and spatial epigenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial genomics and transcriptomics market also includes sales of spatial transcriptomics platforms, imaging systems, and sequencing instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Spatial Genomics And Transcriptomics Market Report 2026?

The spatial genomics and transcriptomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the spatial genomics and transcriptomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.